Glenmark Pharmaceuticals Ltd. — filings
Every filing on record for this company. Each row opens the document it names.
| Filing | Period | Scope / kind | Filed | Document |
|---|---|---|---|---|
| Results XBRL (NSE) | 2018-03-31 | Consolidated | — | INDAS_36357_13417_30052018071148_WEB.xml |
| Results XBRL (NSE) | 2018-03-31 | Standalone | — | INDAS_36364_13430_30052018073208_WEB.xml |
| Results XBRL (NSE) | 2018-09-30 | Standalone | — | INDAS_40979_60008_14112018062253_WEB.xml |
| Results XBRL (NSE) | 2018-09-30 | Consolidated | — | INDAS_40986_60033_14112018063023_WEB.xml |
| Results XBRL (NSE) | 2018-12-31 | Standalone | — | INDAS_43442_83432_15022019041519_WEB.xml |
| Results XBRL (NSE) | 2018-12-31 | Consolidated | — | INDAS_43443_83437_15022019041949_WEB.xml |
| Results XBRL (NSE) | 2019-03-31 | Standalone | — | INDAS_45441_106719_30052019042443_WEB.xm |
| Results XBRL (NSE) | 2019-03-31 | Consolidated | — | INDAS_45448_106736_30052019044222_WEB.xm |
| Results XBRL (NSE) | 2019-06-30 | Standalone | — | INDAS_47904_132153_14082019042818_WEB.xm |
| Results XBRL (NSE) | 2019-06-30 | Consolidated | — | INDAS_47912_132176_14082019043535_WEB.xm |
| Results XBRL (NSE) | 2019-09-30 | Standalone | — | INDAS_51058_172116_15112019044940_WEB.xm |
| Results XBRL (NSE) | 2019-09-30 | Consolidated | — | INDAS_51061_172126_15112019045122_WEB.xm |
| Results XBRL (NSE) | 2019-12-31 | Standalone | — | INDAS_54474_222617_14022020084212_WEB.xm |
| Results XBRL (NSE) | 2019-12-31 | Consolidated | — | INDAS_54476_222620_14022020084437_WEB.xm |
| Results XBRL (NSE) | 2020-03-31 | Standalone | — | INDAS_56839_270288_27062020060040_WEB.xm |
| Results XBRL (NSE) | 2020-03-31 | Consolidated | — | INDAS_56841_270295_27062020060550_WEB.xm |
| Results XBRL (NSE) | 2020-06-30 | Standalone | — | INDAS_60408_307754_15082020035856_WEB.xm |
| Results XBRL (NSE) | 2020-06-30 | Consolidated | — | INDAS_60409_307757_15082020040121_WEB.xm |
| Results XBRL (NSE) | 2020-09-30 | Standalone | — | INDAS_63625_356702_07112020084337_WEB.xm |
| Results XBRL (NSE) | 2020-09-30 | Consolidated | — | INDAS_63626_356705_07112020084540_WEB.xm |
| Results XBRL (NSE) | 2020-12-31 | Standalone | — | INDAS_68973_409520_13022021041753_WEB.xm |
| Results XBRL (NSE) | 2020-12-31 | Consolidated | — | INDAS_68975_409532_13022021042111_WEB.xm |
| Results XBRL (NSE) | 2021-03-31 | Standalone | — | INDAS_70676_453244_29052021090323_WEB.xm |
| Results XBRL (NSE) | 2021-03-31 | Consolidated | — | INDAS_70677_453247_29052021090526_WEB.xm |
| Results XBRL (NSE) | 2021-06-30 | Standalone | — | INDAS_75878_507409_14082021015714_WEB.xm |
| Results XBRL (NSE) | 2021-06-30 | Consolidated | — | INDAS_75880_507420_14082021020233_WEB.xm |
| Results XBRL (NSE) | 2021-09-30 | Standalone | — | INDAS_79162_557628_13112021014124_WEB.xm |
| Results XBRL (NSE) | 2021-09-30 | Consolidated | — | INDAS_79165_557638_13112021014359_WEB.xm |
| Results XBRL (NSE) | 2021-12-31 | Standalone | — | INDAS_82685_609325_12022022061406_WEB.xm |
| Results XBRL (NSE) | 2021-12-31 | Consolidated | — | INDAS_82686_609331_12022022061634_WEB.xm |
| Results XBRL (NSE) | 2022-03-31 | Standalone | — | INDAS_86134_665327_28052022044104_WEB.xm |
| Results XBRL (NSE) | 2022-03-31 | Consolidated | — | INDAS_86136_665334_28052022044305_WEB.xm |
| Results XBRL (NSE) | 2022-06-30 | Standalone | — | INDAS_652667_2790_11082022161151_WEB.xml |
| Results XBRL (NSE) | 2022-06-30 | Consolidated | — | INDAS_652668_2790_11082022161151_WEB.xml |
| Results XBRL (NSE) | 2022-09-30 | Standalone | — | INDAS_864802_5131_12112022150535_WEB.xml |
| Results XBRL (NSE) | 2022-09-30 | Consolidated | — | INDAS_864803_5131_12112022150535_WEB.xml |
| Results XBRL (NSE) | 2022-12-31 | Standalone | — | INDAS_89661_791999_11022023024531.xml |
| Results XBRL (NSE) | 2022-12-31 | Consolidated | — | INDAS_89662_792002_11022023024705.xml |
| Results XBRL (NSE) | 2023-03-31 | Standalone | — | INDAS_92233_848000_20052023061001.xml |
| Results XBRL (NSE) | 2023-03-31 | Consolidated | — | INDAS_92234_848008_20052023061255.xml |
| Results XBRL (NSE) | 2023-06-30 | Consolidated | — | INDAS_96727_916196_11082023074912.xml |
| Results XBRL (NSE) | 2023-06-30 | Standalone | — | INDAS_96728_916208_11082023075206.xml |
| Results XBRL (NSE) | 2023-09-30 | Standalone | — | INDAS_100572_986490_10112023093233.xml |
| Results XBRL (NSE) | 2023-09-30 | Consolidated | — | INDAS_100573_986493_10112023093451.xml |
| Results XBRL (NSE) | 2023-12-31 | Standalone | — | INDAS_104238_1055813_14022024075013.xml |
| Results XBRL (NSE) | 2023-12-31 | Consolidated | — | INDAS_104241_1055824_14022024075210.xml |
| Results XBRL (NSE) | 2024-03-31 | Standalone | — | INDAS_107169_1138567_24052024102116.xml |
| Results XBRL (NSE) | 2024-03-31 | Consolidated | — | INDAS_107170_1138570_24052024102342.xml |
| Results XBRL (NSE) | 2024-06-30 | Standalone | — | INDAS_112340_1226752_14082024065713.xml |
| Results XBRL (NSE) | 2024-06-30 | Consolidated | — | INDAS_112345_1226774_14082024070033.xml |
| Results XBRL (NSE) | 2024-09-30 | Standalone | — | INDAS_116582_1314341_15112024013642.xml |
| Results XBRL (NSE) | 2024-09-30 | Consolidated | — | INDAS_116585_1314352_15112024013820.xml |
| Results XBRL (NSE) | 2024-12-31 | Standalone | — | INDAS_120749_1385440_14022025081311.xml |
| Results XBRL (NSE) | 2024-12-31 | Consolidated | — | INDAS_120751_1385449_14022025081504.xml |
| Results XBRL (NSE) | 2025-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1449738_23052025 |
| Results XBRL (NSE) | 2025-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1449744_23052025 |
| Results XBRL (NSE) | 2025-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1513343_14082025 |
| Results XBRL (NSE) | 2025-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1513345_14082025 |
| Results XBRL (NSE) | 2025-09-30 | Standalone | — | INTEGRATED_FILING_INDAS_1575953_14112025 |
| Results XBRL (NSE) | 2025-09-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1575958_14112025 |
| Results XBRL (NSE) | 2025-12-31 | Standalone | — | INTEGRATED_FILING_INDAS_1615277_30012026 |
| Results XBRL (NSE) | 2025-12-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1615278_30012026 |
| Results XBRL (NSE) | 2026-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1677062_29052026 |
| Results XBRL (NSE) | 2026-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1677091_29052026 |
| Results XBRL (NSE) | 2026-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1680950_11062026 |
| Results XBRL (NSE) | 2026-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1706355_31072026 |
| Results XBRL (NSE) | 2026-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1706356_31072026 |
| Results XBRL (BSE) | 2018-06-30 | Consolidated | 2018-08-11T15:50:36 | Main_Ind_As_532296_108201822318.xml |
| Results XBRL (BSE) | 2018-06-30 | Standalone | 2018-08-11T15:50:36 | Main_Ind_As_532296_1182018155026.xml |
| Results XBRL (BSE) | 2018-09-30 | Standalone | 2018-11-14T18:17:02 | Main_Ind_As_532296_14112018181629.xml |
| Results XBRL (BSE) | 2018-09-30 | Consolidated | 2018-11-14T18:17:02 | Main_Ind_As_532296_14112018181736.xml |
| Results XBRL (BSE) | 2018-12-31 | Standalone | 2019-02-15T15:52:27 | Main_Ind_As_532296_1522019155152.xml |
| Results XBRL (BSE) | 2018-12-31 | Consolidated | 2019-02-15T15:52:27 | Main_Ind_As_532296_1522019155256.xml |
| Results XBRL (BSE) | 2019-03-31 | Standalone | 2019-05-30T16:10:29 | Main_Ind_As_532296_305201916108.xml |
| Results XBRL (BSE) | 2019-03-31 | Consolidated | 2019-05-30T16:10:29 | Main_Ind_As_532296_3052019161156.xml |
| Results XBRL (BSE) | 2019-06-30 | Standalone | 2019-08-14T16:17:25 | Main_Ind_As_532296_1482019161715.xml |
| Results XBRL (BSE) | 2019-06-30 | Consolidated | 2019-08-14T16:17:25 | Main_Ind_As_532296_148201916182.xml |
| Results XBRL (BSE) | 2019-09-30 | Standalone | 2019-11-15T16:25:57 | Main_Ind_As_532296_15112019162434.xml |
| Results XBRL (BSE) | 2019-09-30 | Consolidated | 2019-11-15T16:25:57 | Main_Ind_As_532296_15112019162716.xml |
| Results XBRL (BSE) | 2019-12-31 | Standalone | 2020-02-14T20:28:03 | Main_Ind_As_532296_1422020202743.xml |
| Results XBRL (BSE) | 2019-12-31 | Consolidated | 2020-02-14T20:28:03 | Main_Ind_As_532296_142202020338.xml |
| Results XBRL (BSE) | 2020-03-31 | Standalone | 2020-06-27T17:50:17 | Main_Ind_As_532296_2762020174951.xml |
| Results XBRL (BSE) | 2020-03-31 | Consolidated | 2020-06-27T17:50:17 | Main_Ind_As_532296_2762020175121.xml |
| Results XBRL (BSE) | 2020-06-30 | Standalone | 2020-08-15T15:55:05 | Main_Ind_As_532296_1582020155454.xml |
| Results XBRL (BSE) | 2020-06-30 | Consolidated | 2020-08-15T15:55:05 | Main_Ind_As_532296_1582020155545.xml |
| Results XBRL (BSE) | 2020-09-30 | Standalone | 2020-11-07T20:38:20 | Main_Ind_As_532296_7112020203746.xml |
| Results XBRL (BSE) | 2020-09-30 | Consolidated | 2020-11-07T20:38:20 | Main_Ind_As_532296_7112020203912.xml |
| Results XBRL (BSE) | 2020-12-31 | Standalone | 2021-02-13T16:12:09 | Main_Ind_As_532296_1322021161143.xml |
| Results XBRL (BSE) | 2020-12-31 | Consolidated | 2021-02-13T16:12:09 | Main_Ind_As_532296_1322021161317.xml |
| Results XBRL (BSE) | 2021-03-31 | Standalone | 2021-05-29T21:15:42 | Main_Ind_As_532296_295202121151.xml |
| Results XBRL (BSE) | 2021-03-31 | Consolidated | 2021-05-29T21:15:42 | Main_Ind_As_532296_2952021211713.xml |
| Results XBRL (BSE) | 2021-06-30 | Standalone | 2021-08-14T13:50:14 | Main_Ind_As_532296_148202113502.xml |
| Results XBRL (BSE) | 2021-06-30 | Consolidated | 2021-08-14T13:50:14 | Main_Ind_As_532296_1482021135155.xml |
| Results XBRL (BSE) | 2021-09-30 | Standalone | 2021-11-13T13:49:17 | Main_Ind_As_532296_13112021134833.xml |
| Results XBRL (BSE) | 2021-09-30 | Consolidated | 2021-11-13T13:49:17 | Main_Ind_As_532296_13112021135014.xml |
| Results XBRL (BSE) | 2021-12-31 | Standalone | 2022-02-12T18:07:20 | Main_Ind_As_532296_122202218658.xml |
| Results XBRL (BSE) | 2021-12-31 | Consolidated | 2022-02-12T18:07:20 | Main_Ind_As_532296_122202218841.xml |
| Results XBRL (BSE) | 2022-03-31 | Standalone | 2022-05-30T14:01:30 | Main_Ind_As_532296_2852022162150.xml |
| Results XBRL (BSE) | 2022-03-31 | Consolidated | 2022-05-30T14:01:30 | Main_Ind_As_532296_2852022162410.xml |
| Results XBRL (BSE) | 2022-06-30 | Standalone | 2022-08-12T12:15:33 | Main_Ind_As_532296_118202216015.xml |
| Results XBRL (BSE) | 2022-06-30 | Consolidated | 2022-08-12T12:15:33 | Main_Ind_As_532296_118202216225.xml |
| Results XBRL (BSE) | 2022-09-30 | Standalone | 2022-11-13T12:32:51 | Main_Ind_As_532296_1211202214587.xml |
| Results XBRL (BSE) | 2022-09-30 | Consolidated | 2022-11-13T12:32:51 | Main_Ind_As_532296_1211202215054.xml |
| Annual report | 2000-03-31 | grade A | nan | GLENMARK_PHARMACEUTICALS_LTD-532296-MARCH-2001.PDF |
| Annual report | 2002-03-31 | grade A | nan | GLENMARK_PHARMACEUTICALS_LTD-532296-MARCH-2002.PDF |
| Annual report | 2003-03-31 | grade A | nan | GLENMARK_PHARMACEUTICALS_LTD-532296-MARCH-2003.PDF |
| Annual report | 2004-03-31 | grade B | nan | GLENMARK_PHARMACEUTICALS_LTD-532296-MARCH-2004.PDF |
| Annual report | 2005-03-31 | grade A | nan | GLENMARK_PHARMACEUTICALS_LTD-532296-MARCH-2005.PDF |
| Annual report | 2006-03-31 | grade A | nan | GLENMARK_PHARMACEUTICALS_LTD-532296-MARCH-2006.PDF |
| Annual report | 2007-03-31 | grade A | nan | GLENMARK_PHARMACEUTICALS_LTD-532296-MARCH-2007.PDF |
| Annual report | 2009-03-31 | grade B | nan | GLENMARK_PHARMACEUTICALS_LTD-532296-MARCH-2009.PDF |
| Annual report | 2011-03-31 | grade A | 2011-10-04T00:00:00 | 5322960311.pdf |
| Annual report | 2012-03-31 | grade A | 2012-07-09T00:00:00 | 5322960312.pdf |
| Annual report | 2013-03-31 | grade B | 2013-07-17T00:00:00 | 5322960313.pdf |
| Annual report | 2014-03-31 | grade A | 2014-06-30T00:00:00 | 5322960314.pdf |
| Annual report | 2015-03-31 | grade C | 2015-08-29T00:00:00 | 5322960315.pdf |
| Annual report | 2016-03-31 | grade A | 2016-08-19T00:00:00 | 5322960316.pdf |
| Annual report | 2017-03-31 | grade A | 2017-10-04T00:00:00 | 5322960317.pdf |
| Annual report | 2018-03-31 | grade A | 2018-10-03T00:00:00 | 5322960318.pdf |
| Annual report | 2019-03-31 | grade A | 2019-09-03T00:00:00 | 5322960319.pdf |
| Annual report | 2020-03-31 | grade A | 2020-09-04T00:00:00 | 65970532296.pdf |
| Annual report | 2021-03-31 | grade A | 2021-08-27T00:00:00 | 70071532296.pdf |
| Annual report | 2022-03-31 | grade A | 2022-08-27T00:00:00 | 74780532296.pdf |
| Annual report | 2023-03-31 | grade A | 2023-09-04T20:52:42.927 | 038d73a5-f6a4-4810-a1d3-94e5d02888c8.pdf |
| Annual report | 2024-03-31 | grade A | 2024-09-03T19:35:30.03 | fafa0cb9-ee50-4ae1-abcd-a4d4fe91cd14.pdf |
| Annual report | 2025-03-31 | grade A | 2025-08-29T19:08:35.497 | d3b75907-c1d1-4607-a8d1-7b01cf5078af.pdf |
| Annual report | 2026-03-31 | grade A | 2026-08-13T20:11:49.42 | 1372ff9a-9fa7-4106-979e-d0cfe5c5f8e8.pdf |
| Concall | 2022-03-31 | COVER_LETTER | — | Date_20220603_Glenmark Pharmaceuticals Ltd._Concal_Q4FY22.pd |
| Concall | 2022-06-30 | COVER_LETTER | — | Date_20220817_Glenmark Pharmaceuticals Ltd._Concal_Q1FY23.pd |
| Concall | 2022-09-30 | COVER_LETTER | — | Date_20221118_Glenmark Pharmaceuticals Ltd._Concal_Q2FY23.pd |
| Concall | 2022-12-31 | COVER_LETTER | — | Date_20230215_Glenmark Pharmaceuticals Ltd._Concal_Q3FY23.pd |
| Concall | 2023-03-31 | COVER_LETTER | — | Date_20230525_Glenmark Pharmaceuticals Ltd._Concal_Q4FY23.pd |
| Concall | 2023-06-30 | COVER_LETTER | — | Date_20230821_Glenmark Pharmaceuticals Ltd._Concal_Q1FY24.pd |
| Concall | 2023-09-30 | COVER_LETTER | — | Date_20231120_Glenmark Pharmaceuticals Ltd._Concal_Q2FY24.pd |
| Concall | 2023-12-31 | COVER_LETTER | — | Date_20240219_Glenmark Pharmaceuticals Ltd._Concal_Q3FY24.pd |
| Concall | 2024-03-31 | COVER_LETTER | — | Date_20240529_Glenmark Pharmaceuticals Ltd._Concal_Q4FY24.pd |
| Concall | 2024-06-30 | COVER_LETTER | — | Date_20240820_Glenmark Pharmaceuticals Ltd._Concal_Q1FY25.pd |
| Concall | 2024-09-30 | COVER_LETTER | — | Date_20241121_Glenmark Pharmaceuticals Ltd._Concal_Q2FY25.pd |
| Concall | 2024-12-31 | COVER_LETTER | — | Date_20250219_Glenmark Pharmaceuticals Ltd._Concal_Q3FY25.pd |
| Concall | 2025-03-31 | COVER_LETTER | — | Date_20250527_Glenmark Pharmaceuticals Ltd._Concal_Q4FY25.pd |
| Concall | 2025-09-30 | COVER_LETTER | — | Date_20251119_Glenmark Pharmaceuticals Ltd._Concal_Q2FY26.pd |
| Concall | 2025-12-31 | COVER_LETTER | — | Date_20260204_Glenmark Pharmaceuticals Ltd._Concal_Q3FY26.pd |
| Concall | 2026-03-31 | COVER_LETTER | — | Date_20260605_Glenmark Pharmaceuticals Ltd._Concal_Q4FY26.pd |
| Concall | 2026-06-30 | COVER_LETTER | — | Date_20260805_Glenmark Pharmaceuticals Ltd._Concal_Q1FY27.pd |
| Shareholding XBRL | 2020-09-30 | — | — | SHP_152530_345458_19102020053710_WEB.xml |
| Shareholding XBRL | 2021-09-30 | — | — | SHP_162996_542489_21102021120514_WEB.xml |
| Shareholding XBRL | 2021-12-31 | — | — | SHP_165259_594209_19012022071030_WEB.xml |
| Shareholding XBRL | 2022-03-31 | — | — | SHP_167033_635835_14042022074100_WEB.xml |
| Shareholding XBRL | 2022-06-30 | — | — | SHP_169887_693203_18072022044040_WEB.xml |
| Shareholding XBRL | 2022-09-30 | — | — | SHP_172993_740415_21102022055355_WEB.xml |
| Shareholding XBRL | 2022-12-31 | — | — | SHP_175271_775219_20012023041539_WEB.xml |
| Shareholding XBRL | 2023-03-31 | — | — | SHP_177037_822780_18042023120910_WEB.xml |
| Shareholding XBRL | 2023-06-30 | — | — | SHP_179609_891728_19072023123843_WEB.xml |
| Shareholding XBRL | 2023-09-30 | — | — | SHP_181883_955595_17102023033500_WEB.xml |
| Shareholding XBRL | 2023-12-31 | — | — | SHP_183858_1016798_11012024051632_WEB.xm |
| Shareholding XBRL | 2024-03-31 | — | — | SHP_186938_1093670_16042024014712_WEB.xm |
| Shareholding XBRL | 2024-06-30 | — | — | SHP_190021_1191590_18072024035849_WEB.xm |
| Shareholding XBRL | 2024-09-30 | — | — | SHP_192883_1277690_18102024041504_WEB.xm |
| Shareholding XBRL | 2024-12-31 | — | — | SHP_195588_1352845_20012025045018_WEB.xm |
| Shareholding XBRL | 2025-03-31 | — | — | SHP_197482_1416048_16042025052320_WEB.xm |
| Shareholding XBRL | 2025-06-30 | — | — | SHP_1486453_18072025031754_WEB.xml |
| Shareholding XBRL | 2025-09-30 | — | — | SHP_1547677_14102025044455_WEB.xml |
| Shareholding XBRL | 2025-12-31 | — | — | SHP_1600063_13012026054249_WEB.xml |
| Shareholding XBRL | 2026-03-31 | — | — | SHP_1651479_15042026050854_WEB.xml |
| Shareholding XBRL | 2026-06-30 | — | — | SHP_1693887_16072026123852_WEB.xml |
| Related-party XBRL | 2022-09-30 | — | — | RPT_GLENMARK_28112022171833.xml |
| Related-party XBRL | 2023-03-31 | — | — | RPT_847614_20052023122045_WEB.xml |
| Related-party XBRL | 2023-09-30 | — | — | RPT_986487_10112023092823_WEB.xml |
| Related-party XBRL | 2024-03-31 | — | — | RPT_1138557_24052024101608_WEB.xml |
| Related-party XBRL | 2024-09-30 | — | — | RPT_1313053_14112024080143_WEB.xml |